Current opinion in allergy and clinical immunologyHumansRespiratory Tract InfectionsTh2 CellsAnimalsHypersensitivity
Impact of type 2-targeted therapies on respiratory infection risk.
Kathryn Smiley, Nora Zuhdi, Bob Geng
Published: 202610.1097/ACI.0000000000001134
Abstract
PURPOSE OF REVIEW: To summarize the effects of type 2 (T2) cytokine-targeting therapies on respiratory infection risk in patients with allergic diseases, with a focus on the interplay between epithelial barrier restoration and immune rebalancing. REC…
Preview only. Read the full abstract at the source